Cargando…
Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease
INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213356/ https://www.ncbi.nlm.nih.gov/pubmed/37250400 http://dx.doi.org/10.3389/fnins.2023.1148054 |
_version_ | 1785047603047563264 |
---|---|
author | Lin, Huan-Chun Lin, Kun-Ju Huang, Kuo-Lun Chen, Shih-Hsin Ho, Tsung-Ying Huang, Chin-Chang Hsu, Jung-Lung Chang, Chiung-Chih Hsiao, Ing-Tsung |
author_facet | Lin, Huan-Chun Lin, Kun-Ju Huang, Kuo-Lun Chen, Shih-Hsin Ho, Tsung-Ying Huang, Chin-Chang Hsu, Jung-Lung Chang, Chiung-Chih Hsiao, Ing-Tsung |
author_sort | Lin, Huan-Chun |
collection | PubMed |
description | INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau loading for clinical diagnosis. This study aimed to propose a method for visually interpreting tau-PET using the [(18)F] Florzolotau tracer and investigate the performance and utility of the visual reading. MATERIALS AND METHODS: A total number of 46 individuals with 12 cognitively unimpaired subjects (CU), 20 AD patients with mild cognitive impairment (AD-MCI), and 14 AD with dementia (AD-D) patients with both [(18)F]Florbetapir amyloid PET and [(18)F]Florzolotau tau PET scans were included. Clinical information, cognitive assessment, and amyloid PET scan results were recorded. For visual interpretation, a modified rainbow colormap was created and a regional tau uptake scoring system was proposed to evaluate the degree of tracer uptake and its spatial distribution within five cortical regions. Each region was scored on a scale of [0, 2] as compared to the background, and that resulted in a global scale range of [0, 10]. Four readers interpreted [(18)F]Florzolotau PET using the visual scale. The global and regional standardized uptake value ratios (SUVr) were also calculated for analysis. RESULTS: The result indicates the average global visual scores were 0 ± 0 in the CU group, 3.43 ± 3.35 in the AD-MCI group, and 6.31 ± 2.97 in the AD-D group (p < 0.001). The consensus among the four observers on image scores was high with an intraclass correlation coefficient of 0.880 (95% CI: 0.767–0.936). The average global visual score was significantly associated with global SUVr (r = 0.884, p < 0.0001) and with the CDR-sum of box (r = 0.677, p < 0.0001). CONCLUSION: The visual reading method generated a visual score of [(18)F]Florzolotau tau-PET with good sensitivity and specificity to identify AD-D or CU individuals from the other patients. The preliminary result also showed that the global visual scores are significantly and reliably correlated with global cortical SUVr, and associated well with the clinical diagnosis and cognitive performance. |
format | Online Article Text |
id | pubmed-10213356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102133562023-05-27 Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease Lin, Huan-Chun Lin, Kun-Ju Huang, Kuo-Lun Chen, Shih-Hsin Ho, Tsung-Ying Huang, Chin-Chang Hsu, Jung-Lung Chang, Chiung-Chih Hsiao, Ing-Tsung Front Neurosci Neuroscience INTRODUCTION: Tau-targeted positron emission tomography (tau-PET) is a potential tool for the differential diagnosis of Alzheimer’s disease (AD) and to clarify the distribution of tau deposition. In addition to the quantitative analysis of tau-PET scans, visual reading supports the assessment of tau loading for clinical diagnosis. This study aimed to propose a method for visually interpreting tau-PET using the [(18)F] Florzolotau tracer and investigate the performance and utility of the visual reading. MATERIALS AND METHODS: A total number of 46 individuals with 12 cognitively unimpaired subjects (CU), 20 AD patients with mild cognitive impairment (AD-MCI), and 14 AD with dementia (AD-D) patients with both [(18)F]Florbetapir amyloid PET and [(18)F]Florzolotau tau PET scans were included. Clinical information, cognitive assessment, and amyloid PET scan results were recorded. For visual interpretation, a modified rainbow colormap was created and a regional tau uptake scoring system was proposed to evaluate the degree of tracer uptake and its spatial distribution within five cortical regions. Each region was scored on a scale of [0, 2] as compared to the background, and that resulted in a global scale range of [0, 10]. Four readers interpreted [(18)F]Florzolotau PET using the visual scale. The global and regional standardized uptake value ratios (SUVr) were also calculated for analysis. RESULTS: The result indicates the average global visual scores were 0 ± 0 in the CU group, 3.43 ± 3.35 in the AD-MCI group, and 6.31 ± 2.97 in the AD-D group (p < 0.001). The consensus among the four observers on image scores was high with an intraclass correlation coefficient of 0.880 (95% CI: 0.767–0.936). The average global visual score was significantly associated with global SUVr (r = 0.884, p < 0.0001) and with the CDR-sum of box (r = 0.677, p < 0.0001). CONCLUSION: The visual reading method generated a visual score of [(18)F]Florzolotau tau-PET with good sensitivity and specificity to identify AD-D or CU individuals from the other patients. The preliminary result also showed that the global visual scores are significantly and reliably correlated with global cortical SUVr, and associated well with the clinical diagnosis and cognitive performance. Frontiers Media S.A. 2023-05-12 /pmc/articles/PMC10213356/ /pubmed/37250400 http://dx.doi.org/10.3389/fnins.2023.1148054 Text en Copyright © 2023 Lin, Lin, Huang, Chen, Ho, Huang, Hsu, Chang and Hsiao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Lin, Huan-Chun Lin, Kun-Ju Huang, Kuo-Lun Chen, Shih-Hsin Ho, Tsung-Ying Huang, Chin-Chang Hsu, Jung-Lung Chang, Chiung-Chih Hsiao, Ing-Tsung Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease |
title | Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease |
title_full | Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease |
title_fullStr | Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease |
title_full_unstemmed | Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease |
title_short | Visual reading for [(18)F]Florzolotau ([(18)F]APN-1607) tau PET imaging in clinical assessment of Alzheimer’s disease |
title_sort | visual reading for [(18)f]florzolotau ([(18)f]apn-1607) tau pet imaging in clinical assessment of alzheimer’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213356/ https://www.ncbi.nlm.nih.gov/pubmed/37250400 http://dx.doi.org/10.3389/fnins.2023.1148054 |
work_keys_str_mv | AT linhuanchun visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT linkunju visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT huangkuolun visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT chenshihhsin visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT hotsungying visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT huangchinchang visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT hsujunglung visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT changchiungchih visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease AT hsiaoingtsung visualreadingfor18fflorzolotau18fapn1607taupetimaginginclinicalassessmentofalzheimersdisease |